BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37948362)

  • 1. Benign and Malignant Ovarian Teratomas: Multimodality Imaging Findings With Histopathologic Correlation.
    Laothamatas I; Fang E; Lee J; Abbas SMH; Ding J; Kagen A; Zakashansky K; Taouli B; Kamath A; King MJ
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):882-889. PubMed ID: 37948362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT findings of mature cystic teratoma with malignant transformation: comparison with mature cystic teratoma.
    Park SB; Cho KS; Kim JK
    Clin Imaging; 2011; 35(4):294-300. PubMed ID: 21724123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of gallium-67 within mature and immature teratoma in pediatric patients: investigation for the uptake mechanism.
    Kunieda E; Hara H; Morikawa Y; Hirobe S; Kamagata S; Kubo A
    Ann Nucl Med; 2008 Apr; 22(3):207-13. PubMed ID: 18498036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian teratomas: clinical features, imaging findings and management.
    Saleh M; Bhosale P; Menias CO; Ramalingam P; Jensen C; Iyer R; Ganeshan D
    Abdom Radiol (NY); 2021 Jun; 46(6):2293-2307. PubMed ID: 33394097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of ovarian teratomas in children: a 9-year review.
    Alotaibi MO; Navarro OM
    Can Assoc Radiol J; 2010 Feb; 61(1):23-8. PubMed ID: 19931379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen.
    Emoto M; Obama H; Horiuchi S; Miyakawa T; Kawarabayashi T
    Cancer; 2000 May; 88(10):2298-304. PubMed ID: 10820352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of ovarian teratomas: appearances and complications.
    Choudhary S; Fasih N; Mc Innes M; Marginean C
    J Med Imaging Radiat Oncol; 2009 Oct; 53(5):480-8. PubMed ID: 19788483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
    Balink H; Apperloo MJ; Collins J
    Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-N-methyl-D-aspartate receptor encephalitis induced by bilateral ovarian teratomas with distinct histopathologic types: A case report and brief literature review.
    Li W; Jia D; Tong L; Lun Z; Li H
    Medicine (Baltimore); 2019 Nov; 98(48):e18148. PubMed ID: 31770255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the solid component in predicting malignancy in ovarian cystic teratomas: diagnostic considerations.
    Mlikotic A; McPhaul L; Hansen GC; Sinow RM
    J Ultrasound Med; 2001 Aug; 20(8):859-66; quiz 867. PubMed ID: 11503922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature and immature teratoma: A report from the second Italian pediatric study.
    Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G
    Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas].
    Schmidt D; Kommoss F
    Pathologe; 2007 May; 28(3):203-8. PubMed ID: 17396268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant degeneration of a mature cystic teratoma five decades after discovery.
    Griffiths D; Wass J; Look K; Sutton G
    Gynecol Oncol; 1995 Dec; 59(3):427-9. PubMed ID: 8522269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immature teratoma of the ovary: about a case].
    Bouzoubaa W; Jayi S; Alaoui FZF; Chaara H; Melhouf MA
    Pan Afr Med J; 2017; 27():263. PubMed ID: 29187932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Teratoma in Routine Biopsy Material During a Five-Year Period.
    Kos M; Nikić J; Leniček T
    Acta Clin Croat; 2016 Jun; 55(2):265-70. PubMed ID: 28394114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.
    Yokoyama T; Takehara K; Yamamoto Y; Okame S; Shiroyama Y; Yokoyama T; Nogawa T; Sugawara Y
    Int J Clin Oncol; 2015 Oct; 20(5):960-6. PubMed ID: 25681878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian and non-ovarian teratomas: a wide spectrum of features.
    Saida T; Mori K; Masumoto T; Hoshiai S; Ishiguro T; Sakai M; Hara T; Ochi H; Satoh T; Minami M
    Jpn J Radiol; 2021 Feb; 39(2):143-158. PubMed ID: 32875471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadal teratomas: a review and speculation.
    Ulbright TM
    Adv Anat Pathol; 2004 Jan; 11(1):10-23. PubMed ID: 14676637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of recurrent, bilateral ovarian mature teratoma in a young woman.
    Chang CF; Lin CK
    BMC Womens Health; 2014 Apr; 14():57. PubMed ID: 24726009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.